出血风险-话题@MedSci

#出血风险#

4篇内容 | 1915人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2248927, encodeId=f316224892e5e, content=<a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a>, objectTitle=ORBIT出血风险评分系统, objectType=article, longId=860405, objectId=6df086040568, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250120/1737365815336_8538692.png, objectUrl=/article/show_article.do?id=6df086040568, replyNumber=0, likeNumber=4, createdTime=2025-01-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6df086040568, moduleTitle=ORBIT出血风险评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6df086040568)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2245376, encodeId=61b122453e641, content=<a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a> <a href='/topic/show?id=f6a484255be' target=_blank style='color:#2F92EE;'>#胺碘酮#</a> <a href='/topic/show?id=7f9ae242984' target=_blank style='color:#2F92EE;'>#直接口服抗凝剂#</a>, objectTitle=Eur Heart J-Card Pha：直接口服抗凝剂联合胺碘酮使用时的出血风险, objectType=article, longId=857084, objectId=165985e0846c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721876888294_92910.jpg, objectUrl=/article/show_article.do?id=165985e0846c, replyNumber=1, likeNumber=32, createdTime=2024-12-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=165985e0846c, moduleTitle=Eur Heart J-Card Pha：直接口服抗凝剂联合胺碘酮使用时的出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=165985e0846c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2242409, encodeId=8e7622424090a, content=<a href='/topic/show?id=fe951686621' target=_blank style='color:#2F92EE;'>#ST段抬高型心肌梗死#</a> <a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a>, objectTitle=ARC-HBR高出血风险标准或需更改，漏掉了吸烟这一重要出血危险因素！欧洲心脏杂志子刊研究, objectType=article, longId=854858, objectId=47fd85485848, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241213/1734087070290_8538692.jpg, objectUrl=/article/show_article.do?id=47fd85485848, replyNumber=0, likeNumber=22, createdTime=2024-12-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=47fd85485848, moduleTitle=ARC-HBR高出血风险标准或需更改，漏掉了吸烟这一重要出血危险因素！欧洲心脏杂志子刊研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47fd85485848)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2147261, encodeId=b812214e2612c, content=中国<a href='/topic/show?id=65bf84e44fe' target=_blank style='color:#2F92EE;'>#脑动静脉畸形#</a><a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a>评分系统，<a href='/topic/show?id=66561064130c' target=_blank style='color:#2F92EE;'>#VALE评分#</a>, objectTitle=JAMA Network Open：中国脑动静脉畸形出血风险评分系统开发及验证, objectType=article, longId=781027, objectId=ef14e810270b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230707/d71432514e284fc1943ffb85a24cdcab.jpg, objectUrl=/article/show_article.do?id=ef14e810270b, replyNumber=0, likeNumber=113, createdTime=2023-07-10, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ef14e810270b, moduleTitle=JAMA Network Open：中国脑动静脉畸形出血风险评分系统开发及验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef14e810270b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2147263, encodeId=ca17214e263dc, content=中国<a href='/topic/show?id=65bf84e44fe' target=_blank style='color:#2F92EE;'>#脑动静脉畸形#</a><a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a><a href='/topic/show?id=711891502a5' target=_blank style='color:#2F92EE;'>#评分系统#</a>，<a href='/topic/show?id=66561064130c' target=_blank style='color:#2F92EE;'>#VALE评分#</a>, objectTitle=脑动静脉畸形出血风险评分系统(VALE评分), objectType=scale, longId=3962, objectId=3962, topicUrl=null, isHasObj=0, objectCover=https://static.medsci.cn/public-image/ms-image/c4014af0-a4f3-11ec-a1b8-6123b3ff61ea_企业微信截图_16472234662720.png, objectUrl=https://m.medsci.cn//scale/show.do?id=d6dc396205, replyNumber=0, likeNumber=125, createdTime=2023-07-10, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3962, moduleTitle=脑动静脉畸形出血风险评分系统(VALE评分), moduleType=scale, hrefUrl=https://m.medsci.cn/scale/show.do?id=d6dc396205)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241722, encodeId=cc421241e228b, content=<a href='/topic/show?id=39491046292a' target=_blank style='color:#2F92EE;'>#Asundexian#</a>又是一种新型<a href='/topic/show?id=8516552389b' target=_blank style='color:#2F92EE;'>#抗凝药#</a>物，不知道与<a href='/topic/show?id=f5f610462e09' target=_blank style='color:#2F92EE;'>#Milvexian#</a>比一比，效果如何？这一类药物应该是接班沙班类了。与<a href='/topic/show?id=6a3c61e2e0' target=_blank style='color:#2F92EE;'>#DOAC#</a>治疗相比,Asundexian通过抑制FXIa可以在不干扰止血的情况下预防<a href='/topic/show?id=23c58911686' target=_blank style='color:#2F92EE;'>#血栓栓塞#</a>,从而大大降低<a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a>。, objectTitle=Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）, objectType=article, longId=737263, objectId=9229e37263e8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220828/1661709141854_4754896.png, objectUrl=/article/show_article.do?id=9229e37263e8, replyNumber=0, likeNumber=215, createdTime=2022-08-29, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9229e37263e8, moduleTitle=Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9229e37263e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241723, encodeId=4b211241e23b6, content=新型XIa抑制剂<a href='/topic/show?id=39491046292a' target=_blank style='color:#2F92EE;'>#Asundexian#</a>比<a href='/topic/show?id=95089e7452f' target=_blank style='color:#2F92EE;'>#阿哌沙班#</a>在<a href='/topic/show?id=180251038d2' target=_blank style='color:#2F92EE;'>#心房颤动#</a>患者中更加安全，<a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血风险#</a>更小，可期待, objectTitle=Lancet：新型XIa抑制剂asundexian比阿哌沙班在心房颤动患者中更加安全, objectType=article, longId=723749, objectId=0e27e237490e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220407/1649297917378_2299762.jpg, objectUrl=/article/show_article.do?id=0e27e237490e, replyNumber=0, likeNumber=182, createdTime=2022-08-29, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e27e237490e, moduleTitle=Lancet：新型XIa抑制剂asundexian比阿哌沙班在心房颤动患者中更加安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e27e237490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

出血风险

2020-05-29

梅斯管理员

#出血风险#

ORBIT出血风险评分系统

2025-01-20发表于上海

梅斯管理员

#出血风险# #胺碘酮# #直接口服抗凝剂#

Eur Heart J-Card Pha：直接口服抗凝剂联合胺碘酮使用时的出血风险

2024-12-28发表于陕西省

梅斯管理员

#ST段抬高型心肌梗死# #出血风险#

ARC-HBR高出血风险标准或需更改，漏掉了吸烟这一重要出血危险因素！欧洲心脏杂志子刊研究

2024-12-14发表于陕西省

侠胆医心

中国#脑动静脉畸形##出血风险#评分系统，#VALE评分#

JAMA Network Open：中国脑动静脉畸形出血风险评分系统开发及验证

2023-07-10发表于上海

侠胆医心

中国#脑动静脉畸形##出血风险##评分系统#，#VALE评分#

脑动静脉畸形出血风险评分系统(VALE评分)

2023-07-10发表于上海

循证小兵

#Asundexian#又是一种新型#抗凝药#物，不知道与#Milvexian#比一比，效果如何？这一类药物应该是接班沙班类了。与#DOAC#治疗相比,Asundexian通过抑制FXIa可以在不干扰止血的情况下预防#血栓栓塞#,从而大大降低#出血风险#。

Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）

2022-08-29

循证小兵

新型XIa抑制剂#Asundexian#比#阿哌沙班#在#心房颤动#患者中更加安全，#出血风险#更小，可期待

Lancet：新型XIa抑制剂asundexian比阿哌沙班在心房颤动患者中更加安全

2022-08-29

科室
- - 订阅+
  - 更多科室
工具
服务